ATC Group: A03CA02 Clidinium and psycholeptics

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A03CA02 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A03 Drugs for functional gastrointestinal disorders
3 A03C Antispasmodics in combination with psycholeptics
4 A03CA Synthetic anticholinergic agents in combination with psycholeptics
5 A03CA02 Clidinium and psycholeptics

Active ingredients in A03CA02

Active Ingredient Description
Clidinium

Clidinium is a synthetic anticholinergic that has a spasmolytic effect on smooth muscle and also inhibits secretions.

Related product monographs

Title Information Source Document Type  
LIBRAX Capsule Health Products and Food Branch (CA) MPI, CA: SPM

Medicines in this ATC group

United States (US)

Canada (CA)

Cyprus (CY)

Ecuador (EC)

Finland (FI)

France (FR)

Hong Kong (HK)

Singapore (SG)

Tunisia (TN)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.